Ethical, Legal and Social Aspects research
The acronyms ELSI (in the United States) and ELSA (in Europe) refer to research activities that anticipate and address ethical, legal and social implications (ELSI) or aspects (ELSA) of emerging sciences, notably genomics and nanotechnology. ELSI was conceived in 1988 when James Watson, at the press conference announcing his appointment as director of the Human Genome Project (HGP), suddenly and somewhat unexpectedly declared that the ethical and social implications of genomics warranted a special effort and should be directly funded by the National Institutes of Health. Spread. Various ELSI or ELSA programs have been  developed, in Canada, Europe and the Far East. Overview: Features. At least four features seem typical for an ELSA approach, namely: Reception. The ELSA approach has been widely endorsed by academics studying the societal impact of science and technology, but also criticized. Michael Yesley, responsible for the US Department of Energy (DOE) part of the ELSI programme, claims that the ELSI Program was in fact a discourse of justification, selecting topics of ethics research that will facilitate rather than challenge the advance of genetic technology. In other words, ELSA genomics as the handmaiden of genomics research. In Europe, in the  context of the Horizon 2020 program, ELSA-style research is now usually framed as Responsible Research and Innovation. Examples of academic journals open to publishing ELSA research results are "New Genetics and Society" (Taylor and Francis) and "Life Sciences, Society and Policy" (SpringerOpen).